The Department of Justice on Tuesday sued to prevent UnitedHealth Group from buying Amedisys, a deal the government said ...

The agency’s ability to hire and retain skilled employees may be in jeopardy given Trump ally Robert F. Kennedy Jr.’s ...

The U.S. syphilis epidemic slowed dramatically last year, gonorrhea cases fell and chlamydia cases remained below prepandemic ...

In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

Neurogene shares tumbled 35% last night after it disclosed that a pediatric patient with Rett syndrome experienced a severe ...

For AbbVie, the failure of a high-profile schizophrenia drug hardly marks its last chance to invest in neuroscience. But the ...

The company behind ChatGPT didn’t set out to tackle health care. But despite ongoing concerns about its technology’s tendency ...

Pfizer's head of digital devices says the industry is close to a 'revolution' in using measures from wearables in clinical ...

Scientist Jeffrey Karp has made a name for himself by thinking creatively and boldly. He writes that his ADHD has profoundly ...

LONDON — AstraZeneca said Tuesday it has had to resubmit a closely watched medicine for U.S. approval in a different form of ...

Narcotics Anonymous and Salvation Army are often hostile to use of the addiction medications buprenorphine and methadone.

No FDA-approved rapid tests exist that specifically test for H5N1, and the first near-point-of-care test for mpox was ...